Precigen (PGEN) Enterprise Value (2012 - 2026)
Precigen's (PGEN) quarterly Enterprise Value came in at -$56.2 million in Q1 2026, down 10.89% year-on-year from -$63.1 million in Q1 2025, and up 42.52% on a QoQ basis from -$97.9 million in Q4 2025.
Precigen (PGEN) Enterprise Value (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Enterprise Value data on file, last reported at -$56.2 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 10.89% year-over-year to -$56.2 million in Q1 2026; TTM through Mar 2026 was -$56.2 million, a 10.89% decrease from a year earlier, with the FY2025 full-year figure at -$97.9 million, down 40.41% from the prior year.
- Enterprise Value for Q1 2026 stood at -$56.2 million, up from -$97.9 million in the prior quarter.
- Over the last five years, Enterprise Value for PGEN reached as high as -$10.1 million in Q3 2023 and fell as low as -$121.1 million in Q3 2025.
- Historically, Enterprise Value has averaged -$63.9 million across 5 years, with a median of -$56.2 million in 2026.
- Across the five-year window, Enterprise Value jumped 88.99% in 2023 and slumped 323.09% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$56.0 million in 2022, then retreated by 12.34% to -$62.9 million in 2023, then retreated by 10.88% to -$69.7 million in 2024, then plunged by 40.41% to -$97.9 million in 2025, then soared by 42.52% to -$56.2 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$56.2 million in Q1 2026, -$97.9 million in Q4 2025, and -$121.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | -56.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.25 Mn |
| Dec 31, 2025 | -97.86 Mn |
| Sep 30, 2025 | -121.14 Mn |
| Jun 30, 2025 | -28.87 Mn |
| Mar 31, 2025 | -50.72 Mn |
| Dec 31, 2024 | -69.69 Mn |
| Sep 30, 2024 | -28.63 Mn |
| Jun 30, 2024 | -19.54 Mn |
| Mar 31, 2024 | -44.76 Mn |
| Dec 31, 2023 | -62.86 Mn |
| Sep 30, 2023 | -10.08 Mn |
| Jun 30, 2023 | -16.55 Mn |
| Mar 31, 2023 | -104.09 Mn |
| Dec 31, 2022 | -55.95 Mn |
| Sep 30, 2022 | -91.51 Mn |
| Jun 30, 2022 | -115.30 Mn |
| Mar 31, 2022 | -112.14 Mn |
| Dec 31, 2021 | -72.24 Mn |
| Sep 30, 2021 | -114.41 Mn |
| Jun 30, 2021 | -115.11 Mn |